Generation of Liver Disease-specific Induced Pluripotent Stem Cells Along with Efficient Differentiation to Functional Hepatocyte-like Cells

Overview

Journal Stem Cell Rev Rep

Publisher Springer

Specialty Cell Biology

Date 2010 Sep 8

PMID 20821352

Citations 69

Authors

Arefeh Ghodsizadeh

Adeleh Taei

Mehdi Totonchi

Ali Seifinejad

Hamid Gourabi

Behshad Pournasr

Nasser Aghdami

Reza Malekzadeh

Navid Almadani

Ghasem Hosseini Salekdeh

Hossein Baharvand

Affiliations

Soon will be listed here.

Abstract

The availability of disease-specific induced pluripotent stem cells (iPSCs) offers a unique opportunity for studying and modeling the effects of specific gene defects on human liver development in vitro and for testing small molecules or other potential therapies for relevant liver disorders. Here we report, for the first time, the derivation of iPSCs by the retroviral transduction of Yamanaka's factors in serum and feeder-free culture conditions from liver-specific patients with tyrosinemia, glycogen storage disease, progressive familial hereditary cholestasis, and two siblings with Crigler-Najjar syndrome. Furthermore, they were differentiated into functional hepatocyte-like cells efficiently. These iPSCs possessed properties of human embryonic stem cells (hESCs) and were successfully differentiated into three lineages that resembled hESC morphology, passaging, surface and pluripotency markers, normal karyotype, DNA methylation, and differentiation. The hepatic lineage-directed differentiation showed that the iPSC-derived hepatic cells expressed hepatocyte-specific markers. Their functionality was confirmed by glycogen and lipid storage activity, secretion of albumin, alpha-fetoprotein, and urea, CYP450 metabolic activity, as well as LDL and indocyanin green uptake. Our results provide proof of principal that human liver-disease specific iPSCs present an exciting potential venue toward cell-based therapeutics, drug metabolism, human liver development and disease models for liver failure disorders.

Citing Articles

Advances in liver organoids: model systems for liver disease.

Lee J, Mun S, Shin Y, Lee S, Son M Arch Pharm Res. 2022; 45(6):390-400.

PMID: 35661984 DOI: 10.1007/s12272-022-01390-6.

Elimination of Reprogramming Transgenes Facilitates the Differentiation of Induced Pluripotent Stem Cells into Hepatocyte-like Cells and Hepatic Organoids.

Jeong J, Kim T, Kim M, Jung Y, Kim K, Shim S Biology (Basel). 2022; 11(4).

PMID: 35453693 PMC: 9030920. DOI: 10.3390/biology11040493.

Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery.

Tricot T, Verfaillie C, Kumar M Cells. 2022; 11(3).

PMID: 35159250 PMC: 8834601. DOI: 10.3390/cells11030442.

In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach.

Tabernilla A, Dos Santos Rodrigues B, Pieters A, Caufriez A, Leroy K, Van Campenhout R Int J Mol Sci. 2021; 22(9).

PMID: 34068678 PMC: 8126138. DOI: 10.3390/ijms22095038.

Liver Organoids: Recent Developments, Limitations and Potential.

Harrison S, Baumgarten S, Verma R, Lunov O, Dejneka A, Sullivan G Front Med (Lausanne). 2021; 8:574047.

PMID: 34026769 PMC: 8131532. DOI: 10.3389/fmed.2021.574047.

References

Liu H, Ye Z, Kim Y, Sharkis S, Jang Y . Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology. 2010; 51(5):1810-9. PMC: 2925460. DOI: 10.1002/hep.23626. View

Cowan C, Atienza J, Melton D, Eggan K . Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science. 2005; 309(5739):1369-73. DOI: 10.1126/science.1116447. View

Hotta A, Ellis J . Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states. J Cell Biochem. 2008; 105(4):940-8. DOI: 10.1002/jcb.21912. View

Chen M, Tomkins D, Auerbach W, McKerlie C, Youssoufian H, Liu L . Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat Genet. 1996; 12(4):448-51. DOI: 10.1038/ng0496-448. View

Park I, Zhao R, West J, Yabuuchi A, Huo H, Ince T . Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2007; 451(7175):141-6. DOI: 10.1038/nature06534. View

Seifinejad A, Tabebordbar M, Baharvand H, Boyer L, Hosseini Salekdeh G . Progress and promise towards safe induced pluripotent stem cells for therapy. Stem Cell Rev Rep. 2010; 6(2):297-306. DOI: 10.1007/s12015-010-9121-x. View

Saha K, Jaenisch R . Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell. 2009; 5(6):584-95. PMC: 2921621. DOI: 10.1016/j.stem.2009.11.009. View

Song Z, Cai J, Liu Y, Zhao D, Yong J, Duo S . Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 2009; 19(11):1233-42. DOI: 10.1038/cr.2009.107. View

Sullivan G, Hay D, Park I, Fletcher J, Hannoun Z, Payne C . Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology. 2009; 51(1):329-35. PMC: 2799548. DOI: 10.1002/hep.23335. View

10.

Tzanakakis E, Hsiao C, Matsushita T, Remmel R, Hu W . Probing enhanced cytochrome P450 2B1/2 activity in rat hepatocyte spheroids through confocal laser scanning microscopy. Cell Transplant. 2001; 10(3):329-42. DOI: 10.3727/000000001783986783. View

11.

Basma H, Soto-Gutierrez A, Yannam G, Liu L, Ito R, Yamamoto T . Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology. 2008; 136(3):990-9. PMC: 2732349. DOI: 10.1053/j.gastro.2008.10.047. View

12.

Asgari S, Pournasr B, Hosseini Salekdeh G, Ghodsizadeh A, Ott M, Baharvand H . Induced pluripotent stem cells: a new era for hepatology. J Hepatol. 2010; 53(4):738-51. DOI: 10.1016/j.jhep.2010.05.009. View

13.

Tuschl G, Lauer B, Mueller S . Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism. Expert Opin Drug Metab Toxicol. 2008; 4(7):855-70. DOI: 10.1517/17425255.4.7.855. View

14.

Si-Tayeb K, Noto F, Nagaoka M, Li J, Battle M, Duris C . Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology. 2009; 51(1):297-305. PMC: 2946078. DOI: 10.1002/hep.23354. View

15.

Baharvand H, Hosseini Salekdeh G, Taei A, Mollamohammadi S . An efficient and easy-to-use cryopreservation protocol for human ES and iPS cells. Nat Protoc. 2010; 5(3):588-94. DOI: 10.1038/nprot.2009.247. View

16.

Baharvand H, Kazemi Ashtiani S, Taee A, Massumi M, Valojerdi M, Yazdi P . Generation of new human embryonic stem cell lines with diploid and triploid karyotypes. Dev Growth Differ. 2006; 48(2):117-28. DOI: 10.1111/j.1440-169X.2006.00851.x. View

17.

Mollamohammadi S, Taei A, Pakzad M, Totonchi M, Seifinejad A, Masoudi N . A simple and efficient cryopreservation method for feeder-free dissociated human induced pluripotent stem cells and human embryonic stem cells. Hum Reprod. 2009; 24(10):2468-76. DOI: 10.1093/humrep/dep244. View

18.

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72. DOI: 10.1016/j.cell.2007.11.019. View

19.

Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T . BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics. 2005; 21(21):4067-8. DOI: 10.1093/bioinformatics/bti652. View

20.

Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews P, Beighton G . Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol. 2007; 25(7):803-16. DOI: 10.1038/nbt1318. View